Podcasts about Incredible

We revisit our initial reactions to Chapter One of The Mandalorian as we discuss Dave Filoni's live action directorial debut, the introduction of the Mandalorian, and the surprise ending to the episode.   On this fully armed and operational episode, we discuss: The Mandalorian's action scenes in various cantinas across the galaxy, The mystery of the bounty given to the Mandalorian from Werner Herzog's client character, Incredible droid action from IG-11 as voiced by Taika Waititi, Nick Nolte's Ugnaught character Kuill, The showdown at the Nikto encampment, and The incredible surprise ending to Chapter 1. Thanks for joining us for another episode! Subscribe to Podcast Stardust for all your Star Wars news, reviews, and discussion wherever you get your podcasts. And please leave us a five star review on Apple Podcasts.   Find Jay and her cosplay adventures on J.Snips Cosplay on Instagram. Follow us on social media: Twitter | Facebook | Instagram | Pinterest | YouTube. T-shirts, hoodies, stickers, masks, and posters are available on TeePublic. Find all episodes on RetroZap.com.

Take the Beducated pleasure quiz: https://beducate.me/pd2611-august    A lifetime of longing led Blair Glaser to Siddha Yoga, a movement and community that would later be revealed as a high-control group. The experience impacted her sense of self, her sexuality, and more. Complexities and all, it also brought her healing.    Blair Glaser's book, This Incredible Longing: https://www.blairglaser.com/books   Sign up for August's free email list for occasional updates: https://substack.com/@augustmclaughlin IG: @GirlBonerMedia   FB: @MyGirlBoner  TT:: @augustmclaughlin.gb  augustmclaughlin.com/girlboner    patreon.com/girlboner   Save $15 at Crave! Elegant, woman-designed jewelry and toys: https://lovecrave.com/august  

What if three small changes to your quoting process could help you close a $63,000 sale?Many business owners think improving sales means learning complicated tactics or building complex systems. But the truth is, most deals are won or lost in the small details—especially in how you quote your work. In this episode, you'll hear the real story of a young landscaping business owner who made a few simple adjustments to his quoting process and dramatically improved his chances of winning the deal.Discover how turning your quote into a compelling story can make customers excited to work with you.Learn a simple way to personalize quotes so clients clearly see that you understand exactly what they want.Find out why presenting quotes face-to-face can dramatically increase your close rate.Hit play now to learn the three simple quoting improvements that helped close a $63,000 deal—and how you can apply them to win more sales in your own business.New episodes every Monday, Wednesday and Friday.Book in your ‘Free Quote Audit' nowTo see how we've helped business grow their sales:Read Client ResultsWatch TestimonialsOr email Ben if you would like to get in touch: hello@strongersalesteams.comThis podcast helps the entrepreneur, founder, CEO, and business owner in the trade, construction and industry segments, regain focus, build confidence, and achieve measurable results through powerful sales training, effective sales strategy, and expert sales coaching—guiding every sales leader, sales manager, and sales team in mastering the sales process, optimizing the sales pipeline, and driving business growth while fostering leadership, balance, and freedom amidst overwhelm, stress, and potential burnout, creating lasting peace of mind and smarter decision making for every California business and Australia business ready to scale up with excellence in sales management.

The W-K Boys Team went on a incredible playoff run to close out the 2025-2026 season, including a buzzer-beater on the road and knocking out the #2 seed in Section 1A at the Mayo Civic Center. What a run for the W-K boys!

Incredible stories from around the world and beyond!

This week, we're talking Pokémon Pokopia! Does it live up to the hype? We also discuss Scarlett Hollow, the Life is Strange TV show casting, and more indie game goodness!Timestamps:00:00:00 - Intro00:04:00 - Pokémon Pokopia First Impressions 00:27:30 - You Should Play Scarlett Hollow00:45:00 - The Life is Strange TV Show has Potential 00:55:30 - Dead Cells: Return To Castlevania is Fantastic01:06:00 - Venba is a Joy01:10:30 - OutroRemember to follow us on twitter or bluesky at @hotgamersonly and subscribe to our youtube channel for the video version at youtube.com/hotgamersonly. You can also follow the boys on twitter/bluesky: Ethan @ChaoticAether, Hunter @ReaperHunter23 and Kyle @KDavisSRL.Be sure to also follow us on your favorite podcast service and we greatly appreciate anyone who leaves a review!

Dave Hughes is one of Australia's biggest and best stand-up comedians – and fellow comedians call him 'the GOAT.' A household name who's made sharp wit and larrikin charm his trademark, Hughesy is universally revered by those inside the industry as the comedian's comedian. His career exploded in 1998 with a legendary debut on Hey Hey It's Saturday– so good it was the only stand-up spot replayed on the show's 50th Anniversary Special. From there, he became a breakout star on The Glasshouse, co-founded the iconic Before The Game, delivered unforgettable Hughesy Loses It segments on Rove Live, and was a key pillar in the launch of The Project in 2009, staying for five years. But Dave's never stopped. He's hosted Australia's Got Talent, produced and starred in Hughesy, We Have A Problem, was the only judge to complete all five seasons of Masked Singer Australia, and in 2025 appeared on I'm A Celebrity Get Me Out of Here, Taskmaster Australia, and Talkin' 'Bout Your Generation. His life and comedy were also featured on Australian Story – the most viewed episode of 2025.   While dominating TV, Dave simultaneously conquered radio. From launching Nova 100's breakfast show in 2001 (which ruled ratings for 13 years) to his national drive show and 2DayFM breakfast stint, he's been a ratings powerhouse for over two decades.   Through it all, stand-up remains his true love. He's a road warrior, selling out theatres nationwide for three decades and earning invitations to perform at Montreal's Just For Laughs festival. In 2025, Australians voted Dave the 2nd most popular comedian and radio host in the nation – remarkable for someone who's been essential for almost thirty years.   Whether performing for 50 people or millions on TV, Hughesy delivers exactly what audiences come for: big laughs. And he's never lost the common touch – after every show, he patiently takes photos with fans until the last one has gone home, from 9 year olds to 99 year olds and beyond. David is currently touring and also performing at the Melbourne Comedy Festival soon, check out tickets before they sell out! Links below. We chat about his radical mindset shift, Wayne Dwyer and mindset, worries and letting go, his many jobs before comedy and being fired as a dishwasher, ego, giving up alcohol, radio and ratings, newfound view of success, being on the doll, trending on Twitter + so much more! Check Dave out on: Instagram: https://www.instagram.com/dhughesy/ Website/ tour dates: https://davehughes.com.au/tour-dates/#tourdates Facebook: https://www.facebook.com/officialdavehughes Tiktok: https://www.tiktok.com/@davehughesy ------------------------------------------- Follow @Funny in Failure on Instagram and Facebook https://www.instagram.com/funnyinfailure/ https://www.facebook.com/funnyinfailure/

In episode 2 of Sunday Night's Main Event, Mr. EBay and Dr. Chad discuss various topics related to wrestling, including a review of the latest wrestling video game, a social media clip featuring a unique pizza wrestler, and a detailed analysis of a Fatal Five-Way match featuring popular wrestlers. They also touch on the recent departure of Road Dogg from WWE and engage with a listener in a fun trivia game. In this episode, the hosts engage in a lively wrestling trivia game, showcasing their knowledge of WWE superstars and history. They reminisce about the nostalgic wrestling buddies from the 90s and discuss the resurgence of collectibles in the form of modern wrestling figures. The conversation shifts to the current wrestling card market, highlighting significant sales and auctions, including a notable John Cena card that raises questions about authenticity and seller credibility. The episode wraps up with reflections on the discussions and plans for future episodes.   Chapters 00:00 Introduction and Show Overview 02:54 Wrestling Video Game Discussion 05:57 Social Media Clip of the Week 09:04 Fatal Five-Way Card Talk 18:00 Match Recap and Analysis 23:57 Road Dogg's Departure from WWE 29:02 Four Corners Game with Listener 33:59 The Game Begins: Wrestling Trivia Showdown 36:18 Nostalgia Trip: Remembering Wrestling Buddies 44:53 The Hunt for Collectibles: Big Shots and More 47:44 Wrestling Card Market Insights: Sales and Auctions 58:22 Closing Thoughts: Reflections and Future Plans   Check Out Our Other Content: New Product Releases with Mrs. Doc - Every Wednesday

Henry shares his thoughts on the state high school hockey tournament and the Wild's hope for a long run in the post season.

B"H My heart is filled with gratitude right now. For the holy heroes serving in Tzahal, in the IDF, in the American army, and for their families who carry the weight of that service with them. Their courage and devotion protect lives and stand up for what is good in this world. In Judaism there is a concept called mesirat nefesh, the giving of the soul. When a person devotes themselves completely to what matters most, they touch the highest place of the neshama, a place beyond ego and beyond the self. So many people are living with that spirit right now. For the rest of us, our task is to serve with our own mesirat nefesh. To live our purpose with devotion, to pray, to support, and to strengthen the good in the world. Hashem oz le'amo yiten. Hashem should give His people strength. Hashem yevarech et amo bashalom. May Hashem bless His people with peace. Praying for shalom for Israel, for America, for the people of Iran, and for the entire world. #Peace #IDF #Israel #Iran #USA To watch Torah Thoughts in video format, click HERE Subscribe to the Torah Thoughts BLOG for exclusive written content! Please like, share and subscribe wherever you find this!

On this episode:Benton girls edge out Northside rival Lafayette in an incredible 2 OT game for the Class 4 District 16 Championship.Rock Port girls advance to their 2nd straight final four while South Harrison & Maur Hill girls see their season end.Wanna thank all of our great Sponsors who make all of this possible.Tolly & Associates Little Caesars of St. Joseph John Anderson Insurance, Meierhofer Funeral Home & Crematory HiHo Bar & Grill Barnes Roofing Jayson & Mary Watkins Matt & Jenni Busby Michelle Cook Group Russell Book & Bookball 365 The St. Joseph MustangsB's Tees KT Logistics LLC Hixson-Klein Funeral Home James L. Griffith Law Firm of Maysville Toby Prussman of Premier Land & Auction Group, HK Quality Sheet Metal, Redman Farms of Maysville, Melissa WinnHenke Family Farms, Green Hills Insurance LLC., Cintas, Thrive Family Chiropractic, IV Nutrition of St. Joseph, Roth Kid Nation Serve Link Home Care out of Trenton, Barnett's Floor Renewal LLC., Balloons D'Lux, B3 Renovations, The Hamilton Bank member FDIC, Wompas Graphix & Embroidery of LibertyEllis Sheep Company of Maysville, Bank Northwest of Cameron, Akey's Catering & Event Rentals, Brown Bear of St. Joseph, Wolf Black Herefords, The KCI Basketball Podcast Jacob Erdman - Shelter Insurance of Rock Port, Rob & Stacia Studer, Green Family Chiropractic , Annie & Noah Roseberry of Re/Max Professionals, Moseley Farms, Jake Anderson of Shelter Insurance A slice & a swirl of Maysville Adkison Barber ShopMoyer Concrete of Maysville Cody Vaughn Wealth Advisor with ThriventGallatin Truck & Tractor Grandmas Gun Shop in Agency Nash Gas in Dearborn Accurate Appraisal in St. Joseph Ryan Meyerkorth SeedB.W. Timber of Bethany Mosaic Medical Center of Maryville Exclusive P.R. of Chicago Great Than Financial Hogue Lumber Company of Albany Stifel in ChillicotheUnited Cooperates, INC out of Osborn & Pattonsburg MP and Sons Contracting in Maysville JA White Construction in Maysville BTC Bank Seth & Marcie Davis of the Fitz Group Home and LandGRM Networks Perry Plumming & Septic LLC of Rock PortCitizens Bank and Trust of Rock Port C&M Business Machines Deal Travel and Cruises LLCKovacs FireworksBray Farms of Cameron The Drug Store in Cameron Pettijohn Auto Center in Bethany Terry Implement Co., INC. Of Gallatin Re/Max Partners of Cameron- Dan & Staci Early The Bunker Club of Savannah North Central Missouri College in Trenton & SavannahCooters Plumbing in Lathrop Steven Frieden Excavating Gregg Lawn & Landscape North Mercer Athletic Booster ClubStronger Starts Now Heather Bennett AgencyLathrop Chiropractic CenterWigfield Farms in Chillicothe

Dean is a former UK Special Boat Service (SBS) Operator, Double World Record holder, Humanitarian Evacuation Specialist, Author, TV host, and co-host of a Netflix Series. His career spans elite special operations, international crisis evacuations, leadership in high-performance environments, and keeping up with his wife Alana Stott MBE, a specialist in counter-human trafficking and humanitarian work.Dean's experience and very particular set of skills ( as we say) have placed him in some of the world's most volatile environments. When the October 7 attacks unfolded in Israel, he rapidly deployed to assist with civilian evacuations, coordinating safe routes, logistics, and international transport to move families and students out of the region. Drawing on previous evacuations in Libya and Afghanistan, his approach remained the same: stay calm, remain mission-focused, and solve the problem in front of you.Before this chapter, Dean served in the UK's elite Special Boat Service until a devastating injury ended his operational career. Rather than accept defeat, he redirected the same mindset forged in special operations into endurance sport — setting two world records in cycling while raising millions for mental health charitiesDean's journey has since expanded into media and leadership. He appeared as an instructor on SAS Australia, bringing a different leadership style to the show — calm, analytical, and focused on performance rather than shouty theatrics. He also co-hosts the Netflix series Toughest Forces on Earth, where he travels globally to train with elite military units and test the realities of special operations selection.A key part of Dean's success is the partnership with his wife Alana Stott MBE, who was awarded an MBE for her work protecting vulnerable women and children from human trafficking. Together they operate as a highly effective team — Alana managing complex logistics and humanitarian initiatives while Dean executes operations on the ground.Dean was formally appointed MBE (Member of the Most Excellent Order of the British Empire) in the King's Birthday Honours List 2024. for his services to Humanitarian work, Sport (his world-record endurance cycling expedition) and Mental health awareness and fundraising.Today Dean works in private investment with Silico Capital, applying the same high-performance team mindset developed in special operations to the world of business and leadership. He continues to work in crisis management, while speaking on leadership, resilience, and high-performance teams. He also collaborates with organisations such as Deep End Fitness, where the focus is on mental toughness, discipline, and the power of controlled stress to build stronger leaders.At its core, Dean's story reflects a principle familiar to anyone from the special operations community: helping others. Whether rescuing civilians from conflict zones, setting world records, leading teams, or mentoring others, the mindset remains the same — stay adaptable, stay disciplined, and always find a way to complete the mission.

This week, Jimmy and Dustin join Brad to discuss Resident Evil Requiem, Pokémon Leaf Green, the Marathon server slam, and more! NOTE: Jimmy's audio has some weird spots in the first part of the episode. We fixed it during the episode. Please keep in mind that our timestamps are approximate, and will often be slightly off due to dynamic ad placement. 0:00:00 - Intro0:18:44 - Resident Evil Requiem0:48:23 - Chronos: The New Dawn0:58:53 - Sort it out/Keep it up1:25:20 - Game Recommendation1:27:17 - Looking For Group1:28:05 - Pokémon Leaf Green1:41:16 - Marathon (server slam)2:10:57 - Closing Questions To watch the podcast on YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/LastStandMediaYouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Don't forget to subscribe to the podcast for free wherever you're listening or by using this link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/SummonSign⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you like the show, telling a friend about it would be amazing! You can text, email, Tweet, or send this link to a friend: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/SummonSign⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

Incredible stories from around the world and beyond!

March 5, 2026Have you had your dose of The Daily MoJo today? Download The Daily MoJo App! "Incredible Human Beings | The Daily MoJo Ep:030526"This episode of The Daily Mojo, hosted by Brad Staggs, delves into a wide array of current events and thought-provoking topics. Discussions range from the technological marvels of the B-2 Stealth Bomber and theoretical aircraft to complex legal issues and political commentary on endorsements and election integrity. The program also touches on international military operations, historical oddities, and significant cultural figures.Phil Bell's Morning Update The DATA Centers are NOT the problem:  HEREBrandon Morse - Redstate Author & host of The Brandon Morse YouTube channel-  decided he'd rather be on FOX News than The Daily MoJo today - can you believe that?Brandon's LinktreeOur affiliate partners:Be prepared! Not scared. Need some Ivermection? Some Hydroxychloroquine? Don't have a doctor who fancies your crazy ideas? We have good news - Dr. Stella Immanuel has teamed up with The Daily MoJo to keep you healthy and happy all year long! Not only can she provide you with those necessary prophylactics, but StellasMoJo.com has plenty of other things to keep you and your body in tip-top shape. Use Promo Code: DailyMoJo to save $$Take care of your body - it's the only one you'll get and it's your temple! We've partnered with Sugar Creek Goods to help you care for yourself in an all-natural way. And in this case, "all natural" doesn't mean it doesn't work! Save 15% on your order with promo code "DailyMojo" at SmellMyMoJo.comCBD is almost everywhere you look these days, so the answer isn't so much where can you get it, it's more about - where can you get the CBD products that actually work!? Certainly, NOT at the gas station! Patriots Relief says it all in the name, and you can save an incredible 40% with the promo code "DailyMojo" at GetMoJoCBD.com!Romika Designs is an awesome American small business that specializes in creating laser-engraved gifts and awards for you, your family, and your employees. Want something special for someone special? Find exactly what you want at MoJoLaserPros.com  There have been a lot of imitators, but there's only OG – American Pride Roasters Coffee. It was first and remains the best roaster of fine coffee beans from around the world. You like coffee? You'll love American Pride – from the heart of the heartland – Des Moines, Iowa. AmericanPrideRoasters.com   Find great deals on American-made products at MoJoMyPillow.com. Mike Lindell – a true patriot in our eyes – puts his money where his mouth (and products) is/are. Find tremendous deals at MoJoMyPillow.com – Promo Code: MoJo50  Life gets messy – sometimes really messy. Be ready for the next mess with survival food and tools from My Patriot Supply. A 25 year shelf life and fantastic variety are just the beginning of the long list of reasons to get your emergency rations at PrepareWithMoJo50.comStay ConnectedWATCH The Daily Mojo LIVE 7-9a CT: www.TheDailyMojo.com Rumble: HEREOr just LISTEN:The Daily MoJo ChannelBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-daily-mojo-with-brad-staggs--3085897/support.

Incredible stories from around the world and beyond!

Dr. Monty Pal and Dr. Andrea Apolo discuss practice-changing studies and other novel approaches in bladder, kidney, and prostate cancers that were presented at the 2026 ASCO Genitourinary Cancers Symposium. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcast. I'm your host, Dr. Monty Pal. I'm a medical oncologist, professor and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles.  And today is super exciting, we're highlighting key abstracts that were presented at the 2026 ASCO GU Cancers Symposium, and I'm just delighted to be joined by the chair of this year's meeting, who is also a dear friend, Dr. Andrea Apolo. Dr. Apolo serves within the Center for Cancer Research at the NCI as head of the Bladder Cancer Section, and she is also acting deputy chief of the Genitourinary Malignancies Branch.  Welcome, Andrea, it is so great to have you on the podcast. Dr. Andrea Apolo: Oh, thank you so much for having me. What a great ASCO that we had, it is really exciting, lots of really great data. So I look forward to chatting about it. Dr. Monty Pal: Excellent. And you know, our full disclosures are available in the transcript of this episode in case our listeners want to have a peek.  The theme of this year's GU meeting was "Patient-Centered Care: From Discovery to Delivery." I love that theme. And really, this is one of the most competitive meetings out there, more than 850 abstracts being presented on high-impact science. Andrea, I just wanted to get right into it and dive into what I think we both felt were some of the most exciting abstracts of the meeting.  And the first of those is one that I know is near and dear to your heart, being a bladder cancer expert yourself, and that is the KEYNOTE-B15 study presented by Matt Galsky. Can you give us a flavor for what that study entailed and some of the key results? Dr. Andrea Apolo: Yeah, I think this was kind of the missing study that we have been waiting for since we saw the EV-302 data in metastatic disease in the frontline setting. We wanted to know how well this combination would work in muscle-invasive bladder cancer patients. And we saw half of that puzzle, you can say half of the piece of the puzzle, when we saw the data at ESMO, the EV-303 data in patients that were cisplatin-ineligible. And then now we are getting the full story with patients that are platinum-eligible, cisplatin-eligible, with the EV-304 data. So that study randomized patients to receive chemotherapy, so different than the EV-303 where the patients were randomized just to receive the radical cystectomy. These patients were randomized to receive neoadjuvant EV plus pembro and then adjuvant EV plus pembro versus neoadjuvant gemcitabine and cisplatin with no adjuvant component to the control arm. So I think this is a really, really important study. Dr. Monty Pal: And share with us some of the results because this in my mind is definitely practice-changing. This is one of those studies that I think you walked into the office on Monday and you are like, "Okay, this is what I am doing now," right? Dr. Andrea Apolo: Yeah. So the study was positive. The primary endpoint was event-free survival, and it met the primary endpoint. The secondary endpoint of overall survival was also met. So really, really great results. Consistent with what we saw with EV-303, the median event-free survival was not reached for the EV plus pembro arm, and it was 48 months for the patients receiving gem-cis. And then looking at the 24-month estimated event-free survival, it was 79% for the EV plus pembro and 66% for the chemo, the gem-cis arm. And that was a hazard ratio of 0.5. So that is really exciting. That is the event-free survival. And then the overall survival, the medians were not reached for either arm, but when you look at the 24-month estimated overall survival, it was 87% for the EV plus pembro versus 81% for the gem-cis, and that was a hazard ratio of 0.65. So very positive study.  And then another question that we had was the pathologic CR rate. Very consistent with what we saw with the EV-303, the pathologic response rate was about 56% for the patients that received EV plus pembro and about 32%, 33% for the patients that received gem-cis. So very consistent with the findings that we have been kind of seeing in phase 2 studies, and this is a pT0N0, so that is important. Dr. Monty Pal: So Andrea, you know, I think that the big question in folks' minds is at this point, we see the data from NIAGARA, cis-gem-durva, we have now seen this data. Put it into context for us. Is there a patient in this day and age who maybe shouldn't get IO altogether, who should maybe get the NIAGARA regimen as opposed to EV-pembro in this context? What are your thoughts there? Dr. Andrea Apolo: Now, that is a great question. I would say with this data, it is very enticing to give EV pembro to our patients in the perioperative setting, and for that to be the new standard of care for all patients, regardless of cisplatin eligibility. So similar to what we saw with EV-302 really changing the standard of care in the frontline setting, I think these two studies, the EV-303 and the EV-304, change the standard of care for patients with muscle-invasive bladder cancer in the perioperative setting, and this should be the new standard of care if the patients don't have a restriction to receiving an immunotherapy. Dr. Monty Pal: I totally agree with that assessment. It is great to hear it from the expert's mouth as well. Thanks a lot for that, Andrea.  The next abstract I wanted to tackle is one that is, I would say, near and dear to my heart because I know these folks really well. It is led by the SWOG group, and this is SWOG S1602. The number there for the audience gives you a sense of how long the study has been running for. The 16 prefix means it is something that we kicked off back in 2016. So this study is really 10 years in the making, right? So Rob Svatek presented this data. It is interesting, right, because it addresses this issue of the BCG (Bacille Calmette-Guérin) shortage, right, where we have needed to sort of rely potentially on other alternative sources or regimens and so forth. Tell us about this trial, Andrea. Dr. Andrea Apolo: This is one of my favorite studies. We talked about putting it in the main oral abstracts, but we put it in one of the educational sessions that talked about non-muscle-invasive bladder cancer because we thought that would be the best audience for it. But it doesn't take away from how important this abstract is, and the tremendous effort that went into the study. Almost a thousand patients enrolled. I think 984 were eligible to enroll in this study. So it is a very high enrolling, randomized, cooperative group study in high-grade non-muscle-invasive bladder cancer. And really the study was designed to address two questions. One is the BCG shortage and can we use a different strain, Tokyo versus TICE? And whether there is a priming effect if you gave intradermal BCG to patients with non-muscle-invasive bladder cancer, can that enhance the effect if you gave it a little bit earlier? I think the study is really important, and it met its primary endpoint, which was it is not inferior to TICE. The findings were really terrific in terms of the outcomes. Numerically. When you look at the endpoint, it looked like the Tokyo strain was as good, if not maybe a little bit better, but not statistically significant than the TICE. And then they broke it down by carcinoma in situ, they broke it down by papillary tumors, and the Tokyo strain was non-inferior in both of those instances. But interestingly, the intradermal BCG did not change outcomes. There was really no priming effect, which was really backed up by pre-clinical data that there would be, but there wasn't a priming effect when the intradermal BCG was given in the Tokyo strain. So that was a really, really interesting finding. But a great study, really important outcomes in the field for non-muscle-invasive bladder cancer. Dr. Monty Pal: Totally. And it just seems like we can't get away from BCG, right? You know, as hard as we try, I mean, I appreciate the studies that sort of build on it that are emerging right now, but it seems like BCG at least for the foreseeable future is kind of here to stay, right? Dr. Andrea Apolo: It works. It is one of the most effective treatments we have for non-muscle-invasive bladder cancer. So, you know, I think it is here to stay and, you know, we need to find alternatives in terms of strains so we don't deal with this shortage that we have been dealing with for so many years now. Dr. Monty Pal: Yeah, indeed. Moving on to some of the other highlighted studies from the meeting, you had mentioned the EV-303 data, so we probably don't need to rehash that study design in much detail. But there was also a rapid oral abstract presented by Dr. Ullén that I think is of interest here, right, that really hones in on pathologic outcomes and DFS from that trial. Do you mind just outlining that for our listenership? Dr. Andrea Apolo: This is the KEYNOTE-905, also known as the EV-303 study. This is a follow-up to the EV-303 data looking at the pathologic response rates, looking at the downstaging effect, looking at the surgical margins after treatment with the neoadjuvant EV plus pembro in the 303. Now, remember in the 303, patients got three cycles of neoadjuvant EV plus pembro and then six cycles in the adjuvant setting. A little bit different than the 304, where they got four cycles, which is really kind of the standard in the neoadjuvant setting, and then five cycles in the adjuvant setting. So still a total of nine cycles. But in the 303, the treatment arm had no systemic therapy, so it was just radical cystectomy. And they looked at the negative margins that you get with the EV plus pembro treatment, which was 92.6% versus 79% with patients receiving just the surgery alone. And then the pathologic CR rate, there was more follow-up on that, it was 57% for the patients receiving EV plus pembro, and as we would expect, about 9% for the patients that just went on to surgery alone because you can achieve a pathologic response rate with TURBT alone. Then they looked at the pathologic downstaging, so anything less than a pT2, and that was 66% in the patients that received the EV plus pembro. So very interesting findings, and it is also really just nice to have now the EV-304 data, like I was saying, there were two pieces of it, the cisplatin-eligible and the cisplatin-ineligible, and just to have those contemporary controls are really important. How did the cisplatin-ineligible do versus the cisplatin-eligible patient in terms of the event-free survival and in terms of the overall survival? So I feel like now we have all of this data that we can kind of put together in the perioperative setting and we can really inform our patients a little bit more about their outcomes depending on whether they are cisplatin-eligible or not, which you know cisplatin-ineligible patients often just, they are sicker, they may have obstruction, their tumors may be larger, they just tend to be a more delicate population than the cisplatin-eligible patients. So not surprisingly, you know, we see that in the EV-303 the disease-free survival for the patients is pretty poor. So the disease-free survival that was reported for this follow-up of the specific abstract was 23.6 months for the patients that just got surgery, and it was not reached for the patients that had the EV plus pembro, and that was a hazard ratio of 0.37. Dr. Monty Pal: Excellent, excellent distillation. So Andrea, in the interest of time, I mean, we could probably talk about bladder cancer forever, but I am going to move us on to the subject of kidney cancer. We have two late-breaking abstracts, LITESPARK-011, which looked at lenvatinib and belzutifan versus cabozantinib in the advanced setting, and then we have an adjuvant study, LITESPARK-022, that looked at pembrolizumab with or without belzutifan in the adjuvant setting. Both studies positive. One for progression-free survival, the other for disease-free survival. Both I think making a big dent in how we treat kidney cancer. Can you tell us a little bit about that? Dr. Andrea Apolo: Yeah, we have been waiting for these trials for a long time. So one of the things that we have been talking about at GU ASCO is to have plenary sessions. And if we would have had a plenary session, these two abstracts would have been part of it because they are important data, really big studies where we are trying to improve the outcomes of our patients with kidney cancer. So the first one, the LITESPARK-011, like you said, this is for advanced renal cell carcinoma, clear cell renal cell carcinoma, where we really don't have a standard of care after IO therapy, right? So we give IO-IO, we give VEGF-IO, but we don't really have a good standard of care. We usually give monotherapy TKIs. So the combination of belzutifan and lenvatinib versus what a standard of care is, cabozantinib, is really an important question to ask. And you know, this is a pretty large study, about 750 patients were randomized. And belzutifan plus lenvatinib demonstrated an improvement in progression-free survival and overall survival versus cabozantinib, but not overall survival, at least not yet, is what the authors are saying. So for the progression-free survival, the hazard ratio was 0.7 and it was 14.8 months for the combination, belzutifan plus lenvatinib arm versus cabozantinib, which was 10.7 months. So I think that is significant. And for the overall survival, it did favor the combination again with a hazard ratio of 0.85. The median was 35 months versus 28 months for the monotherapy cabozantinib, but it did not reach statistical significance. And the authors said that this will be further tested at a final analysis, these were the interim results.  And for the overall survival, the overall survival was 53% for the combination versus 40%. This is significant. And the CR rates were lowish for both of them, it was like 5% for the combo and 1% for cabo monotherapy. So I think that the findings are important because we don't have a standard of care. And although there is no survival benefit, there was a trend. So I think this could be considered in patients that are fit, a treatment option for these patients in the later line settings. Dr. Monty Pal: Great points. I mean lots of great discussion around toxicity as well as efficacy. I mean certainly this is a regimen that may not be suitable for every patient in my portfolio, but certainly one to consider.  Now Andrea, let's shift focus to LITESPARK-022, the adjuvant trial that I mentioned previously. So this is again looking at pembrolizumab with or without belzutifan, met the primary endpoint of disease-free survival. What are your impressions there of the data? Dr. Andrea Apolo: Yeah, the data looks great. And this was a really large study, 1,800 patients were randomized, and the study met the primary endpoint of disease-free survival, benefiting the combination of pembro plus belzutifan. And that is really terrific. The medians were not reached for either arm. And in terms of the overall survival results, also the medians were not reached, but the hazard ratio was 0.78 and did not reach a statistical significance. So there was again a statistically significant improvement in disease-free survival for the combination of pembrolizumab plus belzutifan, but not an overall survival benefit.  So I guess, Monty, you know, we can kind of talk about what that means. There was a lot of discussion about belzutifan and some of the side effects, specifically anemia and managing anemia in this setting and requirements for transfusions. Generally, the authors said it was well tolerated, but we know that combination studies do have more toxicity. So it may be a select group of patients again, similar to the advanced setting, where we opt for a combination, possibly until we see more follow-up data in terms of the overall survival. Dr. Monty Pal: I have to agree with you. You know, in my group, we have been talking about a lot of pembrolizumab-based studies that are running right now, some through the NCI, some, you know, our own sort of homegrown investigator-sponsored trials, and you know, I think for the foreseeable future we are comfortable just maintaining pembrolizumab. Things might change if, for instance, we ultimately see a survival advantage emerge, but I just have my own personal doubts around that, that will be interesting.  Okay, so now we are going to move to the last disease category that we are going to cover, which is prostate cancer. So there, we have the long-awaited results from the PEACE-3 study. These are the final OS results from this trial looking at enzalutamide with or without radium-223 in metastatic castration-resistant prostate cancer. So Andrea, would love to get your perspectives on this. Dr. Andrea Apolo: Yeah, so this study had been presented before and we had seen positive results for the combination of enzalutamide and radium with some interim overall survival results also showing a benefit. But like you said, these are the final results with a median follow-up of 58 months. So it was really nice to see the final results. And with the combination of enzalutamide and six cycles of radium, it did show an improvement in overall survival with a hazard ratio of 0.76. The median overall survival increased from 32.6 months to 38.2 months with the combination. So that is really great. There was some crossing over of the overall survival curves around 18 months was still seen. And again, there was also an improvement in the rPFS with a hazard ratio of 0.71, and the median rPFS improved from 16.4 to 19 months with the combination. So, you know, we have been awaiting the final results, but we kind of knew a lot about the benefits of the combination. And it is something that is kind of slowly trickling into the community in terms of adapting it and using it. There is more buzz now about it and I think these overall survival results will hopefully shift the community into incorporating the combination in these patients. Dr. Monty Pal: Brilliant. So well said. I mean, Andrea, congratulations on a terrific meeting. You have really done it again. Incredible, incredible output from this year's ASCO GU. I just want to thank you for joining us on the program today. Dr. Andrea Apolo: Oh, thank you so much for having me, Monty. It was really a joy to work with the ASCO team and with all the investigators and the Education Committee and the Scientific Committee. Everyone was really outstanding. So to me it was an honor to be part of this meeting, and I am so happy that it was so successful and really presented some amazing data that I think will be practice-changing to our patients. Dr. Monty Pal: Oh, thanks a ton. And also a huge thanks to our listeners. If you enjoyed the content of today's podcast, please don't forget to like and subscribe to our channel wherever you listen to podcasts. Thanks so much. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:     Dr. Monty Pal   @montypal  Dr. Andrea Apolo @apolo_andrea  Follow ASCO on social media:          ASCO on X    ASCO on Bluesky         ASCO on Facebook          ASCO on LinkedIn          Disclosures:       Dr. Monty Pal:      Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview     Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical     Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis     Dr. Andrea Apolo: No disclosures to report.

Join Paul and Billy on The Toon Review for a full match review of an incredible night on Tyneside.

Brooke's becoming a trend setter, Jose had an awkward run-in with a doppleganger, Alexis' "themed" dinner night wasn't without controversy, and Jeffrey received an INCREDIBLE gift from a complete stranger. It's time to go around the room and share What's On Our Minds!See omnystudio.com/listener for privacy information.

Incredible stories from around the world and beyond!

Vanderbilt hoops legend Ronnie McMahan and his kidney donor Jeremy Cooke joined 3HL to detail their incredible journey that started right here on 3HL.See omnystudio.com/listener for privacy information.

Vanderbilt hoops legend Ronnie McMahan and his kidney donor Jeremy Cooke joined 3HL to detail their incredible journey that started right here on 3HL.See omnystudio.com/listener for privacy information.

Incredible stories from around the world and beyond!

"I just got called a b*tch by the racist" - Senator Thorpe Listen live on the Nova Player. Follow us on Facebook, Instagram & TikTokSee omnystudio.com/listener for privacy information.

Haven't you ever wondered what each of your D&D party member's foot size was?This audio is from Episode 2 of our live-play Pokémon D&D campaign!Incredible animation by  @kyephafakemon  Please check them out!

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3931: Paula Pant explores how the “1% margin for improvement” helped figures like Dave Brailsford and Wilhelm Steinitz achieve extraordinary success through small, consistent gains. By pairing ruthless prioritization with tiny daily improvements, she shows how anyone can transform their finances, habits, and career trajectory over time. Listen to discover how micro-progress, applied deliberately, compounds into remarkable results. Read along with the original article(s) here: https://affordanything.com/one-percent-margin-for-improvement-aggregation-of-marginal-gains/ Quotes to ponder: “We searched for small improvements everywhere. Forget about perfection; focus on progression.” “We tried so hard with all the bells and whistles of marginal gains that our focus was too much on the periphery and not on the core.” “You have to identify the critical success factors and ensure they are in place, and then focus your improvements around them. That was a harsh lesson.” Learn more about your ad choices. Visit megaphone.fm/adchoices

Ian is joined by Mike Dirnt to break down the bass lines that shaped the sound of Green Day. From “Longview” to “Basket Case,” Mike shares how he builds his parts, what inspired them, and how simple ideas turn into massive, melodic bass lines that drive the song. Tone, attack, feel, and singing while playing — it's all here.

The Athletic writer reports on the mood in the post-Man City press conference, which was missing a red-carded Daniel Farke. EXCLUSIVE NordVPN Deal ➼ https://nordvpn.com/tsb · Try it risk-free now with a 30-day money-back guarantee Hosted on Acast. See acast.com/privacy for more information.

Scott and Josh discuss their impressions of the first half of Resident Evil: Requiem. Full plot spoilers from 58:55 Hosted on Acast. See acast.com/privacy for more information.

Incredible stories from around the world and beyond!

Every other movie seems to be touted as a “tour de force”--but Philip Barantini's 2021 look at ninety minutes in the life of a chef and everyone around him really earns that praise. The entire film was shot in one take, not to be “original,” but because doing so reflects the tension and stress of the whole enterprise: a restaurant, like a film, is a complicated ecosystem in which personalities, hang-ups, failures, and backstories collide. Join us for a conversation about how the restaurant is, like so many of our jobs, a petri dish in which radically different people are placed and forced to coexist. Sometimes, things get ugly. Incredible bumper music by John Deley. Adam Reiner's The New Rules of Dining Out explains how restaurants work and complements the film like a Cabernet Sauvignon does a steak. You can also see Adam Reiner being interviewed about his book and favorite restaurant-based films here on Pages and Frames. Please subscribe to the show and consider leaving us a rating or review. You can find over three hundred episodes wherever you get your podcasts. Follow the show on Letterboxd and email us any time at fifteenminutefilm@gmail.com with requests and recommendations. Check out Dan Moran's substack, Pages and Frames, where he writes about books and movies, as well as his many film-related author interviews on The New Books Network. Read Mike Takla's substack, The Grumbler's Almanac, for commentary on offbeat topics of the day. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Every other movie seems to be touted as a “tour de force”--but Philip Barantini's 2021 look at ninety minutes in the life of a chef and everyone around him really earns that praise. The entire film was shot in one take, not to be “original,” but because doing so reflects the tension and stress of the whole enterprise: a restaurant, like a film, is a complicated ecosystem in which personalities, hang-ups, failures, and backstories collide. Join us for a conversation about how the restaurant is, like so many of our jobs, a petri dish in which radically different people are placed and forced to coexist. Sometimes, things get ugly. Incredible bumper music by John Deley. Adam Reiner's The New Rules of Dining Out explains how restaurants work and complements the film like a Cabernet Sauvignon does a steak. You can also see Adam Reiner being interviewed about his book and favorite restaurant-based films here on Pages and Frames. Please subscribe to the show and consider leaving us a rating or review. You can find over three hundred episodes wherever you get your podcasts. Follow the show on Letterboxd and email us any time at fifteenminutefilm@gmail.com with requests and recommendations. Check out Dan Moran's substack, Pages and Frames, where he writes about books and movies, as well as his many film-related author interviews on The New Books Network. Read Mike Takla's substack, The Grumbler's Almanac, for commentary on offbeat topics of the day. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/film

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3931: Paula Pant explores how the “1% margin for improvement” helped figures like Dave Brailsford and Wilhelm Steinitz achieve extraordinary success through small, consistent gains. By pairing ruthless prioritization with tiny daily improvements, she shows how anyone can transform their finances, habits, and career trajectory over time. Listen to discover how micro-progress, applied deliberately, compounds into remarkable results. Read along with the original article(s) here: https://affordanything.com/one-percent-margin-for-improvement-aggregation-of-marginal-gains/ Quotes to ponder: “We searched for small improvements everywhere. Forget about perfection; focus on progression.” “We tried so hard with all the bells and whistles of marginal gains that our focus was too much on the periphery and not on the core.” “You have to identify the critical success factors and ensure they are in place, and then focus your improvements around them. That was a harsh lesson.” Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3931: Paula Pant explores how the “1% margin for improvement” helped figures like Dave Brailsford and Wilhelm Steinitz achieve extraordinary success through small, consistent gains. By pairing ruthless prioritization with tiny daily improvements, she shows how anyone can transform their finances, habits, and career trajectory over time. Listen to discover how micro-progress, applied deliberately, compounds into remarkable results. Read along with the original article(s) here: https://affordanything.com/one-percent-margin-for-improvement-aggregation-of-marginal-gains/ Quotes to ponder: “We searched for small improvements everywhere. Forget about perfection; focus on progression.” “We tried so hard with all the bells and whistles of marginal gains that our focus was too much on the periphery and not on the core.” “You have to identify the critical success factors and ensure they are in place, and then focus your improvements around them. That was a harsh lesson.” Learn more about your ad choices. Visit megaphone.fm/adchoices

Every other movie seems to be touted as a “tour de force”--but Philip Barantini's 2021 look at ninety minutes in the life of a chef and everyone around him really earns that praise. The entire film was shot in one take, not to be “original,” but because doing so reflects the tension and stress of the whole enterprise: a restaurant, like a film, is a complicated ecosystem in which personalities, hang-ups, failures, and backstories collide. Join us for a conversation about how the restaurant is, like so many of our jobs, a petri dish in which radically different people are placed and forced to coexist. Sometimes, things get ugly. Incredible bumper music by John Deley. Adam Reiner's The New Rules of Dining Out explains how restaurants work and complements the film like a Cabernet Sauvignon does a steak. You can also see Adam Reiner being interviewed about his book and favorite restaurant-based films here on Pages and Frames. Please subscribe to the show and consider leaving us a rating or review. You can find over three hundred episodes wherever you get your podcasts. Follow the show on Letterboxd and email us any time at fifteenminutefilm@gmail.com with requests and recommendations. Check out Dan Moran's substack, Pages and Frames, where he writes about books and movies, as well as his many film-related author interviews on The New Books Network. Read Mike Takla's substack, The Grumbler's Almanac, for commentary on offbeat topics of the day. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/food

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3930: Paula Pant explores how the “1 percent margin for improvement,” popularized by Dave Brailsford and echoed by thinkers like Wilhelm Steinitz and Leo Babuta, can transform finances, health, learning, and business results. By pairing ruthless prioritization with tiny, consistent gains, she shows how small daily actions compound into extraordinary outcomes. Listen to discover how micro-progress can help you finally move the needle on the goals that matter most. Read along with the original article(s) here: https://affordanything.com/one-percent-margin-for-improvement-aggregation-of-marginal-gains/ Quotes to ponder: “We searched for small improvements everywhere. Forget about perfection; focus on progression.” “Prioritization is the ‘what.' Marginal gains is the ‘how.'” “One percent improvements create champions over time.” Episode references: Fresh Tilled Soil: https://www.freshtilledsoil.com/ Tour de France: https://www.letour.fr/en/ Harvard Business Review: https://hbr.org/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Liza Mundy reports that after Jennifer Matthews' tragic death, targeters like "Maya" traced Bin Laden's courier to Abbottabad, emphasizing the incredible precision of the analysts' intelligence for the SEALs. 7.1908

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3930: Paula Pant explores how the “1 percent margin for improvement,” popularized by Dave Brailsford and echoed by thinkers like Wilhelm Steinitz and Leo Babuta, can transform finances, health, learning, and business results. By pairing ruthless prioritization with tiny, consistent gains, she shows how small daily actions compound into extraordinary outcomes. Listen to discover how micro-progress can help you finally move the needle on the goals that matter most. Read along with the original article(s) here: https://affordanything.com/one-percent-margin-for-improvement-aggregation-of-marginal-gains/ Quotes to ponder: “We searched for small improvements everywhere. Forget about perfection; focus on progression.” “Prioritization is the ‘what.' Marginal gains is the ‘how.'” “One percent improvements create champions over time.” Episode references: Fresh Tilled Soil: https://www.freshtilledsoil.com/ Tour de France: https://www.letour.fr/en/ Harvard Business Review: https://hbr.org/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3930: Paula Pant explores how the “1 percent margin for improvement,” popularized by Dave Brailsford and echoed by thinkers like Wilhelm Steinitz and Leo Babuta, can transform finances, health, learning, and business results. By pairing ruthless prioritization with tiny, consistent gains, she shows how small daily actions compound into extraordinary outcomes. Listen to discover how micro-progress can help you finally move the needle on the goals that matter most. Read along with the original article(s) here: https://affordanything.com/one-percent-margin-for-improvement-aggregation-of-marginal-gains/ Quotes to ponder: “We searched for small improvements everywhere. Forget about perfection; focus on progression.” “Prioritization is the ‘what.' Marginal gains is the ‘how.'” “One percent improvements create champions over time.” Episode references: Fresh Tilled Soil: https://www.freshtilledsoil.com/ Tour de France: https://www.letour.fr/en/ Harvard Business Review: https://hbr.org/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Steve and Jeff interviewed Erin Hanson, the CEO of Guardian Sports. Hanson discussed the first-ever football helmet chinstrap specifically engineered for impact absorption from facemask blows. The guys also congratulated Will Clapp on a successful NFL career.

Resident Evil Is Incredible, Marathon is almost passed the finish line The best Gaming podcast 576Substack https://substack.com/@acgreviewhttps://amzn.to/43LY1Gv Amazon Affiliate LinkJoin this channel to get access to perks: https://www.youtube.com/channel/UC5zKbGokI0oI6SeZrHTfJjA/join Each Friday ACG and some pals Silver, Rej, Abssi, and Jonny from https://www.twitch.tv/jonnyplayslive get together to discuss games, life, books, movies and everything else. New home of the ACG Best Gaming Podcast Follow me on Twitter for reviews and info @jeremypenter-JOIN the ACG Reddit https://www.reddit.com/r/ACGVids/ https://www.patreon.com/AngryCentaurGaming

Incredible stories from around the world and beyond!

With Carl unavailable because of moving duties, Kevin is back to help breakdown everything in the world of enterteinment.First, Eitan and Kevin deep dive into the world of sports and breakdown the great coverage of the Winter Olympics by NBC/Peacock, and how they proved (again) that they are the best product channel fit in the streaming world.They then chat about how the preparations are going for the upcoming FIFA World Cup, before expressing their flabergastedness (that's not a word, is it?) at BAFTAs broadcast mess after a racial slur went out on air, and the way it was managed afterward raised a lot of questions.Other topics include thoughts on The Knight of The Seven Kingdoms, The Pitt, and Kevin's thoughts on Hamnet.Join us!

In 1968, a bright young woman became the subject of a kidnapping plot cooked up from the mind of a narcissist who thought the world owed him something. Barbara Jane Mackle would find her revenge in a life well-lived.Strange and Unexplained" is a podcast from Grab Bag Collab & Three Goose Entertainment and is a journey into the uncomfortable and the unknowable that will leave you both laughing and sleeping with the lights on. You can get early and ad-free episodes and much more over at www.grabbagcollab.comFollow us on InstagramEpisode Sponsors:Mint Mobile. Ready to stop paying more than you have to? New customers can make the switch today and, for a limited time, get unlimited premium wireless for just $15 per month. Switch now at mintmobile.com/strange Wayfair. Get organized, refreshed, and back on track this new year for WAY less. Head to Wayfair.com right now to shop all things home. Wayfair. Every style. Every home. Factor. Head to factormeals.com/daisyeagan50off and use code daisyeagan50off to get 50% off and free breakfast for a year. Eat like a pro this month with Factor. New subscribers only, varies by plan. 1 free breakfast item per box for 1 year while subscription is activeAvocado Green Mattress. Go to AvocadoGreenMattress.com/STRANGE and check out their mattress and bedding sale!

Seth and Sean briefly discuss a funny flub Seth had in a commercial, dive into the Texans event revealing all that will be the Toro District, and how to pronounce "Bridgeland."

Seth and Sean kick off the show by talking about the big Toro District reveal by the Texans and Reed Sheppard popping off in the Rockets' win over the Kings.

  With  Dr. Jeanie Iberlin Author of The Transformational Power of Feeling   In this episode, I sit down with transformational coach and author Dr. Jeanie Iberlin to explore something we don't talk about enough — the power of feeling.   Not bypassing. Not overthinking. But actually feeling.   Jeanie shares how our emotions are not obstacles — they are doorways. Doorways back to our soul. Doorways to clearing old conditioning, past trauma, and inherited stories that aren't truly ours.   We talk about: ✨ Why feeling is the gateway to transformation ✨ What it really means to clear away conditioning ✨ How to reconnect to who you really are beneath the noise   Her book, The Transformational Power of Feeling, is an invitation to stop running from discomfort and instead allow it to guide you home to yourself.   And at the end of our conversation, Jeanie guides me through a powerful and simple meditation to meet my soul — to quiet the mind, clear the static, and reconnect to that deeper knowing within.   You can do it too.   If you've been feeling disconnected… stuck in your head… or unsure how to access your own inner guidance, this episode is a gentle doorway inward.   Press play. Pause with us. And remember who you are beneath the mental chatter and conditioning.   https://jeanieiberlin.com BUY HER BOOK www.audreysuttonmills.com 

Incredible stories from around the world and beyond!

Wow, what form Zach Galla is in! Recent sends of Hypnotised Minds, Devilution, Return of the Sleepwalker and Shaolin, could be the most impressive run of ascents ever recorded. We really wanted to try and discern what could have led to such form, is it a mentality thing or improvements in strength? What is the optimum level of confidence for repeat sending? Knowing that rich veins of form are often ended with injury when do you take your foot off the gas? Can you stop to enjoy it? All these questions and more are at least partially answered or vaguely talked about in the podcast! If you're enjoying the podcast and would like to support us, please consider checking out our Patreon page: https://www.patreon.com/user?u=70353823Support the show

Incredible catch up with one of my favorite people in the world, BUTTA!Kevin Frazier on his legendary crossover from sports to entertainment, why the Bad Bunny halftime was misunderstood, fatherhood, The FX Sports Show, his Oscars forecast and so much more. Learn more about your ad choices. Visit podcastchoices.com/adchoices